Player FM - Internet Radio Done Right
131 subscribers
Checked 9d ago
जोड़े गए seven सालो पहले
The Lancet and The Lancet Oncology द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री The Lancet and The Lancet Oncology या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Player FM - पॉडकास्ट ऐप
Player FM ऐप के साथ ऑफ़लाइन जाएं!
Player FM ऐप के साथ ऑफ़लाइन जाएं!
In Conversation With... Mark Lythgoe
Manage episode 359162450 series 2409123
The Lancet and The Lancet Oncology द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री The Lancet and The Lancet Oncology या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit".
206 एपिसोडस
Manage episode 359162450 series 2409123
The Lancet and The Lancet Oncology द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री The Lancet and The Lancet Oncology या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit".
206 एपिसोडस
सभी एपिसोड
×L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
Professor Ian Tannock (Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada) discusses his Policy Review on Common Sense Oncology principles for the design, analysis and reporting of phase 3 randomised clinical trials.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Yannick Romero 24:48
24:48
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद24:48![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Yannick Romero (Union for International Cancer Control) discusses his Policy Review on the changing landscape of the national cancer control plans and his work with the international cancer control partnership.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... M Saiful Huq and Mostafa Aziz Sumon 22:15
22:15
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद22:15![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Professor M Saiful Huq (Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, USA) and Dr Mostafa Aziz Sumon (Radiation Oncology, Kurmitola General Hospital, Dhaka, Bangladesh) discuss their Series on Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries.…
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Steven Horwitz 15:07
15:07
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद15:07![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase 2 study of valemetostat in relapsed or refractory peripheral T-cell lymphoma.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Zachary Zumsteg 17:21
17:21
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद17:21![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Zachary Zumsteg (Cedars-Sinai Medical Center, Los Angeles, CA, USA) discusses his Review on the challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... May Abdel-Wahab and Andrew Scott 40:45
40:45
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद40:45![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
May Abdel-Wahab (Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria) and Andrew Scott (Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia) discuss The Lancet Oncology Commission on Radiotherapy and Theranostics.…
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Kanwal Raghav 13:22
13:22
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद13:22![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Kanwal Raghav (Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) discusses his Article entitled, ‘Trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a randomised, multicentre, phase 2 trial’.…
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Emmy Boerrigter 11:41
11:41
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद11:41![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Hisham Mehanna and Sue Yom 36:56
36:56
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद36:56![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Garth Strohbehn and Katie Lichter 24:08
24:08
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद24:08![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Garth Strohbehn (Veteran Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA) and Dr Katie Lichter (University of California, San Francisco, USA) discuss their papers on the environmental impact of cancer treatments and the public harms resulting from it.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... James Shultz, Ana Patricia Ortiz, and Leticia Nogueira 35:05
35:05
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद35:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico), and Dr Leticia Nogueira (American Cancer Society, Georgia, USA) discuss their Personal View entitled, ‘Protecting Caribbean patients diagnosed with cancer from compounding disasters.…
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Bernardo Goulart 11:22
11:22
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद11:22![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Maria Kyrgiou 25:42
25:42
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद25:42![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In a special episode on International Women's Day 2024, we speak with Maria Kyrgiou (Imperial College London, London, UK) about her Essay on innovations and disparities in gynaecological cancer care.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Georgios Lyratzopoulos 34:43
34:43
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद34:43![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia.
L
Listen to The Lancet Oncology
![Listen to The Lancet Oncology podcast artwork](https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/32.jpg 32w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/64.jpg 64w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/128.jpg 128w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/256.jpg 256w, https://cdn.player.fm/images/21846125/series/zLdGLC9vaAKRKXUa/512.jpg 512w)
![Listen to The Lancet Oncology podcast artwork](/static/images/64pixel.png)
1 In conversation with... Mike Sathekge 16:06
16:06
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद16:06![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Professor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।